Comparison of sensory tests and neuronal quantity of peripheral nerves between streptozotocin (STZ)-induced diabetic rats and paclitaxel (PAC)-treated rats

References

• Albers JW, Chaudhry V, Cavaletti G, Donehower RC. 2011. Interventions for preventing neuropathy caused by cisplatin and related compounds. Cochrane database of systematic reviews, CD005228.
   Google Scholar
• Anand P, Terenghi G, Warner G, Kopelman P, Williams-Chestnut RE, Sinicropi DV. 1996. The role of endogenous nerve growth factor in human diabetic neuropathy. Nat Med 2:703–707.
   PubMed Web of Science ®Google Scholar
• Barriere DA, Rieusset J, Chanteranne D, Busserolles J, Chauvin MA, Chapuis L, Salles J, Dubray C, Morio B. 2012. Paclitaxel therapy potentiates cold hyperalgesia in streptozotocin-induced diabetic rats through enhanced mitochondrial reactive oxygen species production and TRPA1 sensitization. Pain 153:553–561.
   PubMed Web of Science ®Google Scholar
• Beiswenger KK, Calcutt NA, Mizisin AP. 2008. Epidermal nerve fiber quantification in the assessment of diabetic neuropathy. Acta Histochem 110:351–362.
   PubMed Web of Science ®Google Scholar
• Edwards JL, Vincent AM, Cheng HT, Feldman EL. 2008. Diabetic neuropathy: Mechanisms to management. Pharmacol Ther 120:1–34.
   PubMed Web of Science ®Google Scholar
• Flatters SJ, Bennett GJ. 2006. Studies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropathy: Evidence for mitochondrial dysfunction. Pain 122:245–257.
   PubMed Web of Science ®Google Scholar
• Flatters SJ, Xiao WH, Bennett GJ. 2006. Acetyl-L-carnitine prevents and reduces paclitaxel-induced painful peripheral neuropathy. Neurosci Lett 397:219–223.
   PubMed Web of Science ®Google Scholar
• Gornstein E, Schwarz TL. 2014. The paradox of paclitaxel neurotoxicity: Mechanisms and unanswered questions. Neuropharmacology 76(Pt A):175–183.
   PubMed Web of Science ®Google Scholar
• Head KA. 2006. Peripheral neuropathy: Pathogenic mechanisms and alternative therapies. Altern Med Rev 11:294–329.
   PubMed Web of Science ®Google Scholar
• Imreova H, Pura M. 2005. [Differential diagnosis of peripheral neuropathy]. Cas Lek Cesk 144:628–633; discussion 633–625.
   PubMedGoogle Scholar
• Jin HY, Kang SM, Liu WJ, Song CH, Lee KA, Baek HS, Park TS. 2012a. Comparison of peripheral nerve damages according to glucose control timing in experimental diabetes. Exp Clin Endocrinol Diabetes 120:451–459.
   PubMed Web of Science ®Google Scholar
• Jin HY, Lee KA, Song SK, Liu WJ, Choi JH, Song CH, Baek HS, Park TS. 2012b. Sulodexide prevents peripheral nerve damage in streptozotocin induced diabetic rats. Eur J Pharmacol 674:217–226.
   PubMed Web of Science ®Google Scholar
• Jin HY, Kim SH, Yu HM, Baek HS, Park TS. 2013. Therapeutic potential of dioscorea extract (DA-9801) in comparison with alpha lipoic acid on the peripheral nerves in experimental diabetes. J Diabetes Res 2013:631218.
   PubMed Web of Science ®Google Scholar
• Kim N, Kim SH, Kim YJ, Kim JK, Nam MK, Rhim H, Yoon SK, Choi SZ, Son M, Kim SY, et al. 2011. Neurotrophic activity of DA-9801, a mixture extract of Dioscorea japonica Thunb. and Dioscorea nipponica Makino, in vitro. J Ethnopharmacol 137:312–319.
   PubMed Web of Science ®Google Scholar
• Lee KA, Jin HY, Baek HS, Park TS. 2013. The protective effects of DA-9801 (Dioscorea extract) on the peripheral nerves in streptozotocin-induced diabetic rats. J Nutr Sci Vitaminol 59:437–446.
   PubMed Web of Science ®Google Scholar
• Liu WJ, Jin HY, Lee KA, Xie SH, Baek HS, Park TS. 2011. Neuroprotective effect of the glucagon-like peptide-1 receptor agonist, synthetic exendin-4, in streptozotocin-induced diabetic rats. Br J Pharmacol 164:1410–1420.
   PubMed Web of Science ®Google Scholar
• Lopez-Hernandez N, Garcia-Escriva A, Pampliega-Perez A, Alvarez-Sauco M, Martin-Estefania C, Asensio-Asensio M. 2003. [Peripheral and optical myeloneuropathy in a folic acid deficient alcoholic patient]. Rev Neurol 37:726–729.
   PubMed Web of Science ®Google Scholar
• Melli G, Taiana M, Camozzi F, Triolo D, Podini P, Quattrini A, Taroni F, Lauria G. 2008. Alpha-lipoic acid prevents mitochondrial damage and neurotoxicity in experimental chemotherapy neuropathy. Exp Neurol 214:276–284.
   PubMed Web of Science ®Google Scholar
• Perkins AT, Morgenlander JC. 1997. Endocrinologic causes of peripheral neuropathy. Pins and needles in a stocking-and-glove pattern and other symptoms. Postgrad Med 102:81–82, 90–92, 102–106.
   PubMed Web of Science ®Google Scholar
• Polomano RC, Bennett GJ. 2001. Chemotherapy-evoked painful peripheral neuropathy. Pain Med 2:8–14.
   PubMed Web of Science ®Google Scholar
• Stevens MJ, Obrosova I, Cao X, Van Huysen C, Greene DA. 2000. Effects of DL-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy. Diabetes 49:1006–1015.
   PubMed Web of Science ®Google Scholar
• Stillman M, Cata JP. 2006. Management of chemotherapy-induced peripheral neuropathy. Curr Pain Headache Rep 10:279–287.
   PubMedGoogle Scholar
• Sun LQ, Chen YY, Wang X, Li XJ, Xue B, Qu L, Zhang TT, Mu YM, Lu JM. 2012. The protective effect of alpha lipoic acid on Schwann cells exposed to constant or intermittent high glucose. Biochem Pharmacol 84:961–973.
   PubMed Web of Science ®Google Scholar
• Tomlinson DR, Gardiner NJ. 2008. Diabetic neuropathies: Components of etiology. J Peripher Nerv Syst 13:112–121.
   PubMed Web of Science ®Google Scholar
• Van Dam PS. 2002. Oxidative stress and diabetic neuropathy: Pathophysiological mechanisms and treatment perspectives. Diabetes Metab Res Rev 18:176–184.
   PubMed Web of Science ®Google Scholar
• Vinik A, Ullal J, Parson HK, Casellini CM. 2006. Diabetic neuropathies: Clinical manifestations and current treatment options. Nat Clin Pract Endocrinol Metab 2:269–281.
   PubMedGoogle Scholar
• Vinik AI, Nevoret ML, Casellini C, Parson H. 2013. Diabetic neuropathy. Endocrinol Metab Clin North Am 42:747–787.
   PubMed Web of Science ®Google Scholar
• Weimer LH. 2003. Medication-induced peripheral neuropathy. Curr Neurol Neurosci Rep 3:86–92.
   PubMedGoogle Scholar
• Weinstein S. 1962. Tactile sensitivity of the phalanges. Percept Mot Skills 14:351–354.
   PubMed Web of Science ®Google Scholar
• Windebank AJ, Grisold W. 2008. Chemotherapy-induced neuropathy. J Peripher Nerv Syst 13:27–46.
   PubMed Web of Science ®Google Scholar
• Yagihashi S, Mizukami H, Sugimoto K. 2011. Mechanism of diabetic neuropathy: Where are we now and where to go? J Diabetes Investig 2:18–32.
   PubMed Web of Science ®Google Scholar